Chemomab Therapeutics Ltd. Liquidation Value Calculator
Chemomab Therapeutics Ltd.
Current Price: N/A
Loading calculator data...
Advanced: All 115 XBRL Tags
Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.
Balance Sheet
| Tag | Value | Unit | ||
|---|---|---|---|---|
| cash | ||||
| Cash And Cash Equivalents At Carrying Value total CashAndCashEquivalentsAtCarryingValue |
$7.56M | USD | ||
| Cash Cash Equivalents And Short Term Investments total CashCashEquivalentsAndShortTermInvestments |
$10.40M | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents total CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
$7.56M | USD | ||
| Restricted Cash Current total RestrictedCashCurrent |
$0 | USD | ||
| current_liabilities | ||||
| Accrued Liabilities Current total AccruedLiabilitiesCurrent |
$337,000 | USD | ||
| Employee Related Liabilities Current total EmployeeRelatedLiabilitiesCurrent |
$656,000 | USD | ||
| Operating Lease Liability Current total OperatingLeaseLiabilityCurrent |
$0 | USD | ||
| liabilities_current | ||||
| Liabilities Current total LiabilitiesCurrent |
$1.48M | USD | ||
| liabilities_total | ||||
| Liabilities total | $1.48M | USD | ||
| operating_lease_liability | ||||
| Operating Lease Liability Current fact OperatingLeaseLiabilityCurrent |
$0 | USD | ||
| Operating Lease Liability Noncurrent fact OperatingLeaseLiabilityNoncurrent |
$0 | USD | ||
Unmapped Tags (102)
| Accounts Payable Trade Current AccountsPayableTradeCurrent | $485,000 | USD | ||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | $311,000 | USD | ||
| Additional Paid In Capital AdditionalPaidInCapital | $123.95M | USD | ||
| Assets Assets | $13.81M | USD | ||
| Assets Current AssetsCurrent | $13.43M | USD | ||
| Assets Noncurrent AssetsNoncurrent | $387,000 | USD | ||
| Common Stock No Par Value CommonStockNoParValue | $0 | USD/shares | ||
| Common Stock Shares Authorized CommonStockSharesAuthorized | $4.65B | shares | ||
| Common Stock Shares Issued CommonStockSharesIssued | $575.38M | shares | ||
| Common Stock Value CommonStockValue | $0 | USD | ||
| Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards | $3.27M | USD | ||
| Deferred Tax Assets Gross DeferredTaxAssetsGross | $49.86M | USD | ||
| Deferred Tax Assets Net DeferredTaxAssetsNet | $0 | USD | ||
| Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards | $44.46M | USD | ||
| Deferred Tax Assets Other DeferredTaxAssetsOther | $8,000 | USD | ||
| Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance | $49.86M | USD | ||
| Deposits Assets Current DepositsAssetsCurrent | $2.80M | USD | ||
| Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding | $575.38M | shares | ||
| Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity | $13.81M | USD | ||
| Liabilities Noncurrent LiabilitiesNoncurrent | $0 | USD | ||
| Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset | $0 | USD | ||
| Property Plant And Equipment Gross PropertyPlantAndEquipmentGross | $487,000 | USD | ||
| Property Plant And Equipment Net PropertyPlantAndEquipmentNet | $176,000 | USD | ||
| Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit | $-111.62M | USD | ||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | $0 | USD | ||
| Stockholders Equity StockholdersEquity | $12.33M | USD | ||
| Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount | $2.92M | USD | ||
| Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense | $623,000 | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | $1.42M | USD | ||
| Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | $374,000 | USD | ||
| Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | $-0 | pure | ||
| Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | $120,000 | USD | ||
| Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade | $-177,000 | USD | ||
| Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities | $-1.20M | USD | ||
| Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities | $-278,000 | USD | ||
| Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability | $-35,000 | USD | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | $1.14M | USD | ||
| Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities | $7.16M | USD | ||
| Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities | $5.39M | USD | ||
| Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities | $-11.13M | USD | ||
| Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment | $3,000 | USD | ||
| Proceeds From Other Equity ProceedsFromOtherEquity | $7.14M | USD | ||
| Proceeds From Sale Of Treasury Stock ProceedsFromSaleOfTreasuryStock | $0 | USD | ||
| Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised | $12,000 | USD | ||
| Share Based Compensation ShareBasedCompensation | $623,000 | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | $810,400 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | $5.87M | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | $10.07M | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | $1.43M | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | $0 | pure | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | $1 | pure | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | $1 | pure | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | $0 | pure | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | $0 | pure | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | $4.87M | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | $4.76M | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | $31.49M | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | $0 | USD/shares | ||
| Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | $0 | USD/shares | ||
| Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | $0 | USD/shares | ||
| Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | $0 | USD/shares | ||
| Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation | $623,000 | USD | ||
| Cost Of Revenue CostOfRevenue | $2.33M | USD | ||
| Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment | $1.74M | USD | ||
| Earnings Per Share Basic EarningsPerShareBasic | $0 | USD/shares | ||
| Earnings Per Share Diluted EarningsPerShareDiluted | $0 | USD/shares | ||
| Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations | $0 | pure | ||
| Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | $-0 | pure | ||
| Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | $-0 | pure | ||
| Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | $0 | pure | ||
| General And Administrative Expense GeneralAndAdministrativeExpense | $3.73M | USD | ||
| Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | $9.04M | USD | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | $-8.99M | USD | ||
| Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | $-40,000 | USD | ||
| Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare | $0 | USD/shares | ||
| Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare | $0 | USD/shares | ||
| Income Tax Expense Benefit IncomeTaxExpenseBenefit | $0 | USD | ||
| Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | $2.30M | USD | ||
| Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther | $5,000 | USD | ||
| Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems | $-344,000 | USD | ||
| Net Income Loss NetIncomeLoss | $-8.99M | USD | ||
| Nonoperating Income Expense NonoperatingIncomeExpense | $572,000 | USD | ||
| Operating Expenses OperatingExpenses | $9.57M | USD | ||
| Operating Income Loss OperatingIncomeLoss | $-112.00M | USD | ||
| Other General And Administrative Expense OtherGeneralAndAdministrativeExpense | $142,000 | USD | ||
| Other Research And Development Expense OtherResearchAndDevelopmentExpense | $108,000 | USD | ||
| Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent | $3.06M | USD | ||
| Prepaid Expense Current PrepaidExpenseCurrent | $2.86M | USD | ||
| Prepaid Expense Noncurrent PrepaidExpenseNoncurrent | $211,000 | USD | ||
| Research And Development Expense ResearchAndDevelopmentExpense | $5.83M | USD | ||
| Royalty Expense RoyaltyExpense | $1.02M | USD | ||
| Depreciation Depreciation | $70,000 | USD | ||
| Professional Fees ProfessionalFees | $1.24M | USD | ||
| Profit Loss ProfitLoss | $-8.99M | USD | ||
| Severance Costs1 SeveranceCosts1 | $42,000 | USD | ||
| Share Price SharePrice | $0 | USD/shares | ||
| Shares Outstanding SharesOutstanding | $575.38M | shares | ||
| Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised | $12,000 | USD | ||
| GeneralInsuranceExpense GeneralInsuranceExpense | $499,000 | USD | ||
| NoninterestExpenseDirectorsFees NoninterestExpenseDirectorsFees | $286,000 | USD | ||
| OfficersCompensation OfficersCompensation | $1.85M | USD | ||
| SalariesAndWages SalariesAndWages | $1.04M | USD |
Showing balance sheet tags only. Liquidation analysis uses balance sheet data.